Icotinib

CAS No.	610798-31-7
MDL No.	MFCD22124501
MF	C₂₂H₂₁N₃O₄
MW	391.40
InChI Key	QQLKULDARVNMAL-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	610798-31-7
Product Name	Icotinib

Biological Targets

EGFR

Associated Conditions

lung cancer·neoplasm·breast cancer·non-small cell lung carcinoma·pancreatic carcinoma·

* The information provided here is compiled from public sources and is for reference only.

Icotinib

CAS No.	610798-31-7
MDL No.	MFCD22124501
MF	C₂₂H₂₁N₃O₄
MW	391.40
InChI Key	QQLKULDARVNMAL-UHFFFAOYSA-N

CUSTOM SYNTHESIS PRECLINICAL SUPPORT

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	610798-31-7
Product Name	Icotinib

Biological Targets

EGFR

Associated Conditions

lung cancer·neoplasm·breast cancer·non-small cell lung carcinoma·pancreatic carcinoma·

* The information provided here is compiled from public sources and is for reference only.

Icotinib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Icotinib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Documentation

Icotinib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells.

Investigation on the protein-binding properties of icotinib by spectroscopic and molecular modeling method.

Icotinib, a selective EGF receptor tyrosine kinase inhibitor, for the treatment of non-small-cell lung cancer.

Icotinib: activity and clinical application in Chinese patients with lung cancer.

Similar Products

Erlotinib Hydrochloride

Erlotinib

6,7-Bis(2-chloroethoxy)-N-(3-ethynylphenyl)quinazolin-4-amine

NRC-2694 hydrochloride

1-(3-((6,7-Bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)ethan-1-one

Gefitinib

Icotinib

Pricing & Availability

Product Information

Biological Profile

Properties

Biological Targets

Associated Conditions

Related Articles

Nrf2 but not autophagy inhibition is associated with the survival of wild-type epidermal growth factor receptor non-small cell lung cancer cells.

Investigation on the protein-binding properties of icotinib by spectroscopic and molecular modeling method.

Icotinib, a selective EGF receptor tyrosine kinase inhibitor, for the treatment of non-small-cell lung cancer.

Icotinib: activity and clinical application in Chinese patients with lung cancer.

Similar Products

Erlotinib Hydrochloride

Erlotinib

6,7-Bis(2-chloroethoxy)-N-(3-ethynylphenyl)quinazolin-4-amine

NRC-2694 hydrochloride

1-(3-((6,7-Bis(2-methoxyethoxy)quinazolin-4-yl)amino)phenyl)ethan-1-one

Gefitinib

Documentation